Lorillard
Fields
- Author
- Huber, G.L.
- Request
- R1-034
- Area
- LEGAL DEPT FILE ROOM
- Site
- N14
- Master ID
- 03749906/0785
- 03749907
- 03749908-9910 Harvard Project Equipment
- 03749911-9912 Harvard Project Equipment
- 03749913-9915
- 03749916-9917 Harvard Project Equipment
- 03749918-9935 Tobacco Industry Equipment Inventory
- 03749936-9938 Harvard Project Equipment
- 03749939-9941 Harvard Project
- 03749942-9963 Compromise Agreement
- 03749964
- 03749965-9966
- 03749967-9970 Tentative Outline Tobacco Smoking and Pulmonary Disease
- 03749971
- 03749972-9973
- 03749974-9975 Harvard Project
- 03749976-9977 Exhibit A
- 03749988-0005 Compromise Agreement
- 03750006-0008 Harvard - Tobacco Companies Settlement
- 03750009-0010 Tobacco and Health Research Project
- 03750011-0012
- 03750013
- 03750014-0015
- 03750016-0017 Harvard Project Equipment
- 03750018-0023
- 03750024 Harvard Research Project
- 03750025
- 03750027
- 03750028
- 03750029
- 03750030-0032
- 03750033 Harvard
- 03750034-0035 Harvard Research Project
- 03750036
- 03750037-0047
- 03750049
- 03750050 Harvard Research Project
- 03750051-0052 Harvard Research Project
- 03750053
- 03750054
- 03750055-0056
- 03750057
- 03750059-0060
- 03750061 Gary Huber Research Equipment-Harvard Project
- 03750072-0073 Presentation of Smoking and Health Research Paper by Dr. Huber
- 03750074-0075 Harvard/Dr. Huber
- 03750076
- 03750077
- 03750078 Dr. Huber's Presentation
- 03750079-0081 $6 Million Granted for Smoking - Health Stu Dies
- 03750082-0083 Dr. Huber's Presentation
- 03750084 Presentation of Smoking and Health Research Paper by Dr. Huber
- 03750085 Harvard
- 03750086
- 03750090 Presentation of Smoking and Health Research Paper by Dr. Huber
- 03750091 Presentation of Smoking and Health Research Paper by Dr. Gary Huber
- 03750092
- 03750093 Presentation of Smoking and Health Research Paper by Dr. Gary Huber
- 03750094-0095
- 03750096
- 03750097-0098
- 03750099
- 03750100
- 03750112
- 03750113
- 03750114
- 03750115-0116
- 03750117
- 03750120
- 03750121-0123
- 03750124
- 03750125 General Bulletin to the Medical and Administrative Staffs
- 03750126-0127
- 03750128-0133
- 03750134
- 03750135-0136
- 03750137
- 03750138
- 03750139
- 03750140-0141 Sample Letter
- 03750142 Harvard University Faculty of Medicine Report of Professional Income
- 03750146
- 03750147
- 03750148
- 03750149-0150
- 03750151-0152
- 03750153
- 03750158
- 03750159-0160
- 03750161-0168 Clinical Ethics
- 03750169
- 03750170
- 03750171
- 03750172-0173
- 03750174-0175
- 03750176-0183 Dup of Id 03750161-0168
- 03750184-0185
- 03750186
- 03750187 Sin and Phin
- 03750189
- 03750190 Nicotine Titration Study
- 03750191
- 03750192-0193
- 03750194-0195
- 03750196
- 03750200
- 03750201-0202
- 03750203 Harvard Research Project
- 03750204-0206
- 03750207-0208
- 03750209-0210 Harvard Research Project
- 03750211-0212
- 03750213-0215 Harvard Smoking and Health Research Project
- 03750216-0217
- 03750218
- 03750219-0220
- 03750221
- 03750222 Pathology Space
- 03750223-0224
- 03750225-0226 Department of Pathology Laboratory
- 03750227
- 03750229 Personnel
- 03750230 Christine Segalla Termination
- 03750231 Speed Letter Christine Segalla - Termination
- 03750232-0233 Beth Israel Hospital Notice of Termination
- 03750234-0237 Harvard Smoking and Health Research Project
- 03750238
- 03750239-0240 Da-00566-05 Numerical Density of Secretory Cells
- 03750241
- 03750242
- 03750243-0255 Dean Tosteson and the Tobacco Industry
- 03750256-0258 Harvard Research Project
- 03750259
- 03750260
- 03750261
- 03750262-0263
- 03750264
- 03750265-0267
- 03750268 Harvard Research Project
- 03750269-0271 Harvard Smoking and Health Research Project
- 03750276-0282
- 03750372-0472 Seminars in Respiratory Medicine
- 03750473-0490 Undergraduate Cirricula in Respiratory Diseases A Regional Analysis of New England Medical Schools
- 03750491-0547 the Second Report to the Ad Hoc Advisory Committee of the Harvard University Tobacco and Health Research Program
- 03750548
- 03750549 Supplement A Appendices I - Xi
- 03750550 Appendix I
- 03750551-0555 Summary Tobacco Industry-Harvard University Meetings
- 03750556-0557
- 03750558-0560 Memorandum of Understanding
- 03750561-0562 (Appendix A) Approval Process for Protocols
- 03750563-0567 (Appendix B) Dr. Huber's Research Programs and Support
- 03750568 (Appendix C)
- 03750569-0570
- 03750571 Appendix C
- 03750572 Renovation Cost Estimate
- 03750573-0576
- 03750577 Appendix II
- 03750578-0580 Phaseout Costs of Tobacco Grant
- 03750581 Phaseout Costs of Tobacco Grant
- 03750582-0591 Termination Projections
- 03750592 Appendix III
- 03750593-0595 Dr. Gary Huber's Research Facilities
- 03750596 6 Charlesgate West Boston, Massachusetts
- 03750597 Appendix IV
- 03750598 Organizational Chart Harvard University Tobacco and Health Research Program
- 03750599
- 03750600-0601
- 03750602-0603
- 03750604-0605
- 03750606
- 03750607
- 03750608 Appendix V
- 03750609-0623 Speaking Manuscript Intestinal Parasites of the White Carneau Pigeon
- 03750624-0641 Speech Manuscript Some Normal Hematological Values of the White Carneau Pigeon
- 03750642 Intestinal Parasites of the White Carneau Pigeon
- 03750643 Some Normal Hematological Values of the White Carneau Pigeon
- 03750644 Appendix Vi
- 03750645-0647
- 03750648 Appendix I Technical Proposal for Program Extension
- 03750649-0650 Technical Proposal,Inhalation Bioassay of Cigarette Smoke in Pigeons Extended Protocol
- 03750651-0657 Appendix II Pigeon Population Projections
- 03750658-0669 Appendix III Pigeon Life Tables and Projected Animal Death Rates
- 03750670 Appendix IV Budget Projections
- 03750671 Contract Pricing Proposal
- 03750672-0673 Supplementary Budget
- 03750674 Appendix Vii
- 03750675
- 03750676-0681 Cardiovascular Effects of Cigarette Smoke
- 03750682 Acute Hemodynamic Effects of Cigarette Smoking in Man Assesed by Non-Invasive Technics
- 03750683-0704 Acute Hemodynamic Effects of Cigarette Smoking in Man Assessed by Non-Invasive Technics
- 03750705 Appendix Viii
- 03750706-0720 the Effect of Tobacco Nicotine Content on Cigarette Smoking Behavior in Man
- 03750721 the Effect of Tobacco Nicotine Content on Cigarette Smoking Behavior in Man
- 03750722-0723 Harvard Study Suggests Low Tar Cigarette Risk
- 03750724 Letter to the Editor Tar, Nicotine and Tobacco Smoking
- 03750725 'tar' May Be Down Lung Cancer Isn't
- 03750726-0728 Health Officials Fired Up Over 'tolerable ' Cigarettes
- 03750729 Dr. Gori's Ordeal
- 03750730-0733 Low-Risk Cigarettes: A Prescription
- 03750734 Dr. Gori's Crime: Truth
- 03750735-0736 Joint Statement
- 03750737-0738 Statement by Julius B. Richmond Surgeon General
- 03750739-0740 Less-Toxic Cigarette Stirs Controversy
- 03750741 Despite Study of Low-Tar Cigarettes, Surg Eon General Says None Is Safe
- 03750742 Killing the Messenger
- 03750743 'tolerable' Cigarettes?
- 03750744 Appendix Ix
- 03750759 Appendix X
- 03750760-0761
- 03750762
- 03750763-0779 Harvard University Research Application to the American Petroleum Institute
- 03750780-0785 Appendix Xi
Related Documents:
Document Images
1IIA1Z V'A1LIJ'' ML.l)IiGAL SCll 1UU'L
DEPARTMENT OP' MlDICIN!
~1ilJ
,
11 ETll-1 1SR'AI?L I I(aSIaITAL.
Muir;n,;', Aildresx:
DIVISION OPRHfPIRATORY DISEASES BETH ISRAEL,HOSPITAL
OARY'L. HUSER, M.D., CNItP' 330 BROIDI4LIN6 AVENUL. YOSTON+ MASSACHUSETTS 01218,
(617)'. 736'-2391
October 27, 1978
Mr. Henry C. Meadow
Harvard Medical'' School
25 Shattuck Street
Boston, Massachusetts 02215
Dear Dean Meadow,
I am-attaching a series of schedules that reflect our budgetary
projections for the Smoking and Health Research Program, as well as
summaries of our other research support. We have prepared these schedUles
and projections as a basis for our developing together a more definitive
proposal to present to our tobacco industry gxantors for their progxam at
Harvard University. In that context, they are submitted to you not as
final projections but rather as a first step on which to go forward.
Indev'elopi~ng our projections, we havetried' to follow the guidelines,
.
that were suggested to us by the tobacco industry representatives that met
with us last wi!nter. From our various discussions with you, I apprec,i'atee
that what we have projected may not be in the format or the position that
you would like to present to the industry. I thought it would be hel'pful,
however, to follow their suggestions in developing,this initial presentation
to'you. Thus, the guidelines and assumptions on which we have based these
projections include the following:
1)', Funds fr=the tobacco industry grantors would be extended for
five years (1978-1983) at the current rate of support, with a yearly
increase for infllation. Using the current three years of support
provided through the Extension Agreement, the amount projected for a
newifive-year award would be $4,090,079 for total costs, including
the current overhead allowed'to the University.
2) It was suggested that inclusion of any funds for renovation of
facilities be amorti~zed at 8% over ten years, as an'initial basis
for developing negotiations. We have used the figure of $784,000 for
our share of the laboratory facilities at the Mount Auburn Hospital'
and the animal inhalation quarters at Charlesgate West,, as provided us
by Ms. Sophie Koch-Weser..
3'), The calcula'tion of'the tobacco industry share of the monies
needed for facilities development, as well as for the net/net profit
to Trans National for the Charlesgate facility (which we have expressedd
as the Charlesgate mortgage)~ iis based'on industry-related'animal
utilizationi, floor space utilizationi, and technical/administrative
staff'employment in these facil'ities. The industry share currently
would be represented by,, to our best estimate, approximately 65% of
our total effort, if the Charllesgate facility were fully operational.

Mr. Henry C. Mc.ndow
October 27, 1978
RPage 2
4) Fiir.vl ly, we have assumed that we wi 11 be ahlc to maintain the
current level of Nllii or non-industry support('35p,of total effort).
Actually, if all of'the grants now awarded to us or approved could bee
implemented, the non-industry share would be muchicloser to 50' a' of the
total costs of'our program. If we go forward, we wiSl apply for as
much non-industry support as possible. We have not done so n w, of'
course,, because of the uncertainties of'our future and our priority
requirement to focus on a resolution of'the industry-sponsored program.
The budget projections that we have d'eveliope&ai1so include additional
considerations. We have trimmed our professional personnel and technical
staff somewhat to preserve the very best parts of our program, in the hope
of providing for the University (within the guidelines given to us by the
industry) the maximum amount of funding available for additional consider-
ations. In reducing professional personnel, we have followed the sugges-
tions provided us by the ad hoc Advisory Committee to our research program
at Harvard., ffinal~lly,in developing,these projections,, we have taken the
industry's suggestion that we prepare budgets for aifive-year period, -
assuming,that the grant would~not be renewed and'that there would be a
phase-out period during the last six months of support. This is not to say
that the industry desires to restrict their support to us to the next five
years only, but rather that that would be the extent of their current
commitment. Indeed, by amortizing the renovation costs over ten years, it
was their expression that the research grant could'potentiallly continue
over that same period of'time'. By restricting,their expected current
commitment to us to an initial five years rather than ten however, they
are in effect asking for a'''shared responsibility"' or "risk" by the Univer-
sity to develop both facilities and mechanisms that would assure program
stability. In projecting our budget estimates in this manner additional
monies would have to be identified in any further industry renewal, to
recover the deficit projected for the final six-month phase out period of
1982-83, if the industry support were to go beyond five years.
All budget projections contain a modest contingency factor, to give us
a matgin of'safEty beyond'our identified operating and personneli costs.
A yearly inflation allowance has also been included. The schedulles that we
have prepared are as follows:
Schedule A: Schedule A is a summary of the budgetary projections for
the Smoking and Health Research Program, for industry funds only, for the
next five years. The costs of'renovation are amortized at 8% over 10
years, and both the costs of renovation and the Charlesgate mortgage are
presented'.as 65% of'the total costs for these entries, reflecting the
tobacco industry share of these expenditures. This schedule also includes
an entry for approximately $270,00'0' for equipment,, reflecting our best
estimate of what will be needed to make our laboratory independent in a
new location where research resources are not now readily available. The
largest share of this equipment expenditure is for an electron microscope
and related supporting functions. We have included in thi~s projection a
yearly balance and'a cumulative balance, with overexpenditures relative to
the industry proj'ecti:ons for direct costs bracketed' by parentheses. The
projection for the current budget extenrledlat the current rate of increase

h'1l'. IUenry 1:~~. (ylc~;~klrn~
'
Oc:tober 27' 1978
I' age 3
w;rs clon0w i't lu.nut spc?Ci f i c-:t II I'y ildct.t t, i' C'yi nJt a IOit i vors ilty ovc nccad
a 1 Low:tnee
which is presently available at an additional l'(p", beyond' direct costs fo~t~~
research' for the industry. Therc is a nct positive cumulative balance of
$551',789, iru our projections, liowc:.vcr, wlrich represents the difference
between those direct costs we fieel will be needed to preserve our program
at an acceptable level for i'inclustry suPhort atiul the: amocunt that they have
projected! as potentially available to us as an extension of the current
budget.
Schedule B: Our revi~sed salary schedule for professional personnel
for the curreirt academic year a-re presented in Schedule B, assuming, that
the recently awarded nicotine titration contract from the National Cancer
Institute can be implemcntca'by January 1, 1979. On the average, approximately
60% of'our current professional salary commitments are paid for by tobacco
industry funds, either as direct research costs or as an allocation tolthe.
Cardiopulmonary Clinical Teachin; and Training,flind'. Two add'itional, grants
are potentiallyavail'ablie to us from non-industry sources (identified in
Schedule I)', but have not been included in these projections bccause they
cannot,, as yet, be impliemented'. In addition, there now remains approximately
$3!5, 0001iniuncommited funds inivariousaceounts of' ours from past years,
which does not show up in any of the budget projections. This wila' in part
be negatedi by the unscheduled $15,000 we have paid to Trans National, and!
some of the outstanding renovation expenses for Charlcsgate West.
Scheciule C: Our professional salary projections for the next fi've.
years are presented in Schedule C, allocating approximately 65a of'our
professional costs to tobacco industry funding, and' a5 o to \tIII or non-
industry support. At this timc,, however, none of our grants extend beyond
1980. We have been assured that our NCI contract for the study of' experi-
mentaT atherogenesis in pigeons can be extended bcyond!19S0, and we have
been asked1by them to prepare protocols and budget projections for a two-
year, extension. Similar discussions have accLJrrecl with NIDA for our
marijuana-related research, ancl'with NCI for our nicotine titration studv
if'it can be implemented. Thus, should our proram go forward, I am!contident
we can maintain (or more likely improve) this level of' non-industry support
for our professional personnel. Should we not be able to do so, we wouldl
have to revise the scope of our program to fit the level of'tobacco industry
support. This seems unlikely to me, however, in spite of potential reductionss
in NIIIi fund'inSasthe need totil;htenthenational, economy continues. There
are very few laboratories that can study agents that are appearing in our
environment at an ever incrcasingrate, and both the necd, and support to
test the biol,ol;,ic cl-fects oll ' thcye agents on the host ;tre rapidly expandli.ng,.
Scl6eelulc C af;su incLtides i.ciTuti'r.taCion ol` sulrlnutt tiot' somC inaividuals
before tlic: end of' a I~ot.ciiLlal t1'ive-y!cirr :tw:trcl. 'I'licse rccJuctlons in pctr;;unnci
follow the recommendations of our ad hoc Advisory Committee.
Scharliulc I): This sc-hed'itlc reflects the salaty I)rojcctions for our ~
C+J
technical and administrative staf, ', as these persunncl are tiuw charbcd' to ~
our tobacco industry funds. la'~c have used the current fringe benefit rate, C11
with an increase at 0.31% encEV year. The percentase of'cach person's time ~'
now, spent on industry relntc:cl' activitics, as well as thci'r salary allocat3on,,;b
is 1 istedl next to cach pos.i t ion. The fraction o f ttu f i nal year that 4
individ'uals would' be availablc iff a phase out wcrc implemcnted' in 1982-1983
is included for tHat year, with thc salaxies adjusted,accordingly.

Mr% Iieaia'y C~~., Mt'e~~,ido~~w
'
O4tcoher 27, 1978
PPage 4
Schc(lul'c Is: The operating expenses for each of our admiiniistrative
sections are presented in Schedule E. For the research units,, these
operating,expenses include supplies, travel, medi!cal illustrations and alll
o'ther expenses not involving conunitments to personnel. For the Charlesgate
animali inhalation facility, the operating expenditures also include utilli.ties,,
services, maintenance and supplies, including the cost of anima!ls. These
projections were developed as an extension of our 19'77-78 and 1978'-79
expenditures in these areas. Additional, outstanding current commitments include
anieqiuipment all'ocatiion ($25000) for a smoking, machine, unpaid rent for
Charlesgate West ($24,000), andias yet unpaid renovation and reliated'costs.
Schedule F, Schedule G'iand Schedule H: These schedules are comparablee
to Schedule B, Schedule D and Schedule E, and reflect the currently awardedl
non-tobaccolindustry funding "availlable in these areas. We have included only
the academbc years 1978-79 and 1979L80, in that our;awards presently
available run in part or in total only through that time. If our current
grants were to be extend'ediand renewed, we wouldianticipate a proportionately
higher level of non-industry support in some of'these areas for the years
1980-1983.,
ScheduleI: We havesummarizedi iniSche~duleI our research,fundingby
grants currently available, as well as by those grants pend'ing. With the
exception of the NCI-sponsored Inhaliation Bioassay of Cigarette Smoke in
Pigeons, all of our awards are administered through Harvard Medical School..
The NCI has indicated to us, in the context of'better coordinating our
program administration, their'willingness (actually their desire) to transfer.
the pigeon bioassay contract from the Beth I'sraeli Hospital to Harvard
Medicali School. This would certainly facilitate adjustment of indirect
costs and overhead expenditures amongst the various aspects of our program,
including appropriate allocations for the off-campus facility at Charlesgate.
West. We have i'ncludedithe NCI-sponsoxed Nicotine Titration contract, both
in terms of the current award that is available to us for 1'97g-79'andithe
additonal funding that they already have indi!catedl will be avail'ablie to us
for 1979-80. I would anticipate that this program will continue, and will
grow considerably in scope if we are successful in the first year or so of
our effort.
We have two additional grants that we have listed as pending. The
first of'these is a contract, to be awarded through the American Petroleum
Institute, to evaluate the carcinogenic potential of certain petroleumm
products. Our proposal was the most cost-effective;-of those submitted' but
we can not implement it until our animal facilii~ti~es are renovated. The
second pending proposal is a grant, already approved, to study lung macro-
phages, lung injury and tobaccoismoke through support from the Nationali
Institute of Environmental Sciences. This program will require the capacity
for our handling a large number of rodents, which we could not do at this
time, unless the Charlgesgate West facility were to be renovated',, along the
plans proposed by Ms. hoch-lVeser. 0,
~.
We will be available to discuss these projections and devellop with you ~'
any changes you want to suggest. I hope these schedules will be helpful to O
our initial efforts.,
Sincerely, 00
GLPl:mtc Gary L. Huber, M'. Di. Chief'
Enclosures Respiratory Diseases lJfiilt
~~.

SCHEDULE A
Sll'+QMARY
SMOKING F, HEALTH RESEARCH PROGRAM
PROJECTED FIVE-YEAR BUDGET
(Tobacco Funds Only)
197 + 8-79 1979-80 1980-81 1981-82 1982-83 Five-year Total
-
Costs of renovation
($-51,000 anorti7ed
-
at 3%, 10 %-ears*=) $75, 945 $75, 945 $75, 945 $75,945 $75,945 $379,725
Chsrles7ate >iortga;e= 23,400 23,400 23,400 23,400 23,400 117,000
Direct Costs
Personnel
363,391
400,779
404,915
419,976
362,132
1,951,193
Operating costs 150,344 160,877 170,799 181,368 139,299 802
687
Subtotal 513,735 561,656 575,714 601-,34-4 501,431 ,
2,753,880
Equipment 269,685 8,000 6,000 4,000 --- 287,685
Total 882,765 669,001 681,059 704,689 600,776 338,290
Current bud~et extended
at current rate of
increase
708,565
761,342
815,326
872,317
932,529
4,090,079
Balance (174,200) 92,341 134,267 167,628 331,753 551,789+
Cumulative Balance ($174,200) ($81,859) $52,408+ $220,036+ $551,789+
*Based on end-of-year annual payments.
=Based on 6~o payable by Tobacco Award
O Amount overextended beyond budget projection
GtFLQS44P..Q

el~N ~ ^
SCHEDULE_ 6_
PROFESSIONAL SALARY SCHEDULE
-------------
REVISED SALARY SCHEDULE (7/1/78 - 6/30/79)
Professional Staff Only
Salary
7/1/78-
6/30/79 Pigeon ,
Contract Tobacco Clinical
Award Training Marijuana
Grant Nicotine
Titration*
Davies, P ' $29, 700 $7, 425 (25 a) $19, 305 (65%) --- '$2,970(100) ---
Drath, D. 29,700 7,425(25%) 20,790(70%) --- 1,485(50) ---
HaYashi,@t. 28,600 5, 720 (20%) 20, 020 (70%) --- 2,860(10%) ---
Huber, G.
41,500
14,525(35%) 13,750(33%) 6,225(15%) 7,000(17%)
Rubin, A. 20,000 --- 7,000(35%) 9, 500 (48%) --- 3, 500 (17 0)
Sakuri, T. 14,200 --- 3, 550 (25%) 10,650(75%) --- ---
Sornberger, G. 29,700 8,910(30%) 12,711(43%) ---. 2,079(7%) 6,000(20%)
- ----------- ------------------------------------------ ------------
----
- - -
Ellenbogen
M 000
4 ---
,
. , -- --- --- 4,000(10%)
---------------------------------------------------------------------------------------------
First, M. 2,000 --- 2,000
Grubner, P. 26,200 6,700(26%) 19,500(74%)
Hinds, W. 14,400 3, 540 (25%) 10, 860 (75%)
Subtotal $240,000 $54,245 $115,736 $33,900 $15,619 $20,500
Fringe (19.2%) 46,080 10,415 22,221 6,509 . 2,999 3,936
TOTAL $286,080 $64,660 $137,957 $40,409 $18,618 $24,436
0SZ4OS44C0
*Awarded by NCI at present, not implemented

~
SCHEDULE C
PROFESSIONAL SALARY SCHEDULE
PROJECTED FIVE-YEAR BUDGET
1978-79
Tobacco NIH 1979-80
Tobacco 1980-81
NIH Tobacco NIH 1981-82
Tobacco NIH
- 1982-83
Tobacco NIH
2avies, P. $19,305 $10,395 $20,930 $11 ,270 $22,555 $12,145 $24,180 $13,020 $25,805 $13,895
Drata, D.. 20,790 8,910 20,930 11 ,270 22,555 12,145 24,180 13,020 25,805 13,895
1ay2_hi, M. 20,020 8,580 10,010 4 ,290 --- --- ---
;luber, G. 13,750 27,750 22,000 22 ,000 23,250 23,250 24,500 24,500 25,750 25,750
?ubin, A. 16,500 3,500 3,500 - -- --- ---. --- --- --- ---
Sakurai, T. 14,200 --- (15,400)# - -- (16,500)# --- (17,900)# --- (19,000)# ---
5ornbzr;er, G. 12,711 1,6,989 20,930 11 ,270 22,555 12,145 24,180 13,020 25,805 13,895
----------------------------------------------------------------------------------------------------
---------------------
=11en'.,:~;en, 1. --- 4,000 2,600 1,400 2,600 1,400 2,600 1,400 2,600 1,400
----------------------------------------------------------------------------------------------------
---------------------
---
:irs:, `:. 2,000 --- 2,000 --- 2,000 --- 2,000 --- 2,000 ---
-rubner, 0. 19,500 6,700 8,900 6,000
aincs, 10,860 3,540 10,110 5,440 10,920 5,880
----------------------------------------------------------------------------------------------------
---------------------
:.ubtetal $149,636 $90,364 $137,310 $72,940 $122,935 $66,965 $119,540 $64,960 $126,765 $68,835
Frince(19.2`-e)* 28,730 17,350 26,775 14,223 24,340 13,259 23,819 13,057 22,730 14,042
TOTAL $178,366 $107,714 $164,085 $87,165 $147,275 $80,224 $143,359 $78,017 $149,495 $82,877
TS4QS4co
10.5, ~ increase per year-
-- -
=O Indicates optional salary not now commited
NIH -\ational Institutes of Health or other non-tobacco indus'try support

I
r"
SCHEDULE D
Administration.
adninistrator (75%)
Admin. Assistant (7S$)
Secretary II (100%)
Secretary II (50%)
3iostatistics
Data Processor (50%)
Analytical Chemistry
Research Assistant (60%)
Research Technician (50%)
3iochemistrY
Research Assistant (100%)
Research Technician (100%)
'4orphology
---Re-search Assistant (100%)
Research Technician (100%)
Research Technician (100%)
Inha_lation Facility
Supervisor (65%)
Assistant Supervisor (65%)
-- -
?la. hine Operator (200%)
Animal Handlers (400%)
tlousekeeping (50%)
5ubtotal
y Fringe
16.-'°e c 0.3", inc./yr.
TOTAL
O __ $ tobacco industry effort
Zs4o94eo
^
TECtINICAL/ADNINISTRATIVE SALARY SCHEDULE
PROJECTED FIVE-YEAR BUDGET
(Tobacco Funds Only)
1978-79 1979-80 1980-81 1981-82 1982-83
$ --- $18,750 $20,250 $21,870 $23,620
11,580 12,391 13,258 14,186 15,179
10,300 11,021 11,792 12,617 13,500
4,250 4,548 4,866 5,207 11,142
7,000 7,490 8,014 8,575 9,175
9,000 9,630 10,304 11,025 5,898(1/2)
6,000 6,420 6,869 7,350 7,765
12,500 13,375 - 14,311 15,313 8,193(1/2)
10,500 11,235 12,021 12,862 6,881(1/2)
12,500 13,375 14,311 15,313 16,385
5,250(1/2) 11,235 12,021 12,862 6,881(1/2)
--- 8,426(3/4) 12,021 12,862 6,881(1/2)
10,725 11,476 12,279 13,138 10,543(3/4)
8,125 8,694 9,303 9,954 5,326(1/2)
18,000 19,260 20,608 22,051 11,797(1/2)
30,000 32,100 34,347 36,751 19,662(1/2)
3,500 3,745 4,007 4,287 2,294(1/2)
$159,230 $203,171 $220,582 $236,223 $181,122 $1,000,328
25,795 33,523 37,058 40,394 51,515 168,285
$185,025 $236,694 $257,640 $276,617 $212,637 $1,168,613
I

SCHEDULE
OPERATING EXPENSES
PROJECTED FIVE-YEAR BUDGET
(Tobacco Funds Only)
1978-79 1979-80 1980-81 1981-82 1982-83 Five-year Total
?ro;raI1
ac_-ini_tration (1)
$47,.436
$50,990
$53,869
$56,921
$60,695
$269,911
3iqstatistics(3) 9,812 10,322 10,726 11,160 ~ 11,696 53,716
.ync:ytic Chemistry (2) 8,569 9,254 9,902 10,496 5,248 43,469
?io-hemistrY (2) 14,226 15,364 16,439 17,563 8,795 72,387
''orohoioga (2) 12,185 13,160 14,081 15,067 7,534 62,027
Clinical/Physiology (2) 14,300 14,644 14,969 15,317 12,659 71,889
.~:harlesc-ate Inhalation
Fa;.ility (3)
43,816
47,143
50,813
54,844
32,672
229,288
TOTAL $150,344 $160,877 $170,799 $181,368 $139,299 $802,687
;1) Supplies, travel, medical illustrations, services, other
Supplies, travel, medical illustrations, other
Utilities, services, maintenance, animals, supplies, other
y3ditional Current Commitments
Equipment Allocation $25,000
,:harlesc-ate Rental Allocation 24,400
Alterations, Renovations and
Special Contingencies
25,000
$74,400
ES~,OSt~~O

(0"~'
SCHEDUL~ F
PROFESSIONAL SALARY SCHEDULE
PROPOSED SALARY SCHEDULE (7/1/79-6/30/80)
(Non-Tobacco Funds)
:'rofessional Staff Only
S Salary
7/1/79-
6/30/80 Pigeon
Contract Marijuana
Grant Nicotine
Titration*
Davies, P. $32, 200 $4, 000 $3, 220 $-,-
Drath, D. 32,200 4,000 3,220
Havashi,M. 14 , 300+ 2,860 2,860 ---
Huber, G. 44,000 7,700 6,600 3,750
Sornber,-er, G. 32,200 4,830 2,255 3,250
----------------------------------------------------------------------------------------------------
--------------
Ellenbogen, M. --- --- --- 1,400
----------------------------------------------------------------------------------------------------
--------------
- ---
Grubner, 0. 14,900+ 3,870 ---
Hinds, 1i. 15,550 1,940 --- , ---
----------------------------------------------------------------------------------------------------
---------------
Subtotai $185,s'50 $29,200 $16,545 $8,400
Fringe (19.5Q) 36,143 5,695 3,226 1,638
Total $221,493 $34,895 $19,771 $10,038
* Awarded by NCI at present, not implemented
+ Six months of support only (7/1/79-6/30/80)
